| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:44 UTC |
|---|
| HMDB ID | HMDB0014749 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Butorphanol |
|---|
| Description | Butorphanol is only found in individuals that have used or taken this drug. It is a synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain. [PubChem]The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Butorphanol is a mixed agonist-antagonist that exerts antagonistic or partially antagonistic effects at mu opiate receptor sites, but is thought to exert its agonistic effects principally at the kappa and sigma opiate receptors. |
|---|
| Structure | [H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1 InChI=1S/C21H29NO2/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15/h6-7,13,15,19,23-24H,1-5,8-12,14H2/t19-,20+,21+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Butorfanol | HMDB | | Butorphanol tartrate | HMDB | | 17-(Cyclobutylmethyl)morphinan-3,14-diol | HMDB | | Apo-butorphanol | HMDB | | Apotex brand OF butorphanol tartrate | HMDB | | Beforal | HMDB | | Bristol-myers squibb brand OF butorphanol tartrate | HMDB | | Cephalon brand OF butorphanol tartrate | HMDB | | Dolorex | HMDB | | Fort dodge brand OF butorphanol tartrate | HMDB | | Geneva brand OF butorphanol tartrate | HMDB | | Intervet brand OF butorphanol tartrate | HMDB | | Moradol | HMDB | | Stadol | HMDB | | Stadol NS | HMDB | | Torbugesic | HMDB |
|
|---|
| Chemical Formula | C21H29NO2 |
|---|
| Average Molecular Weight | 327.4605 |
|---|
| Monoisotopic Molecular Weight | 327.219829177 |
|---|
| IUPAC Name | (1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-4,10-diol |
|---|
| Traditional Name | butorphanol |
|---|
| CAS Registry Number | 58786-99-5 |
|---|
| SMILES | [H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1 |
|---|
| InChI Identifier | InChI=1S/C21H29NO2/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15/h6-7,13,15,19,23-24H,1-5,8-12,14H2/t19-,20+,21+/m0/s1 |
|---|
| InChI Key | IFKLAQQSCNILHL-PWRODBHTSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenanthrenes and derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenanthrenes and derivatives |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Phenanthrenes and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenanthrene
- Benzazocine
- Tetralin
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Piperidine
- Cyclic alcohol
- Tertiary alcohol
- 1,2-aminoalcohol
- Tertiary amine
- Tertiary aliphatic amine
- Azacycle
- Organoheterocyclic compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.16 g/L | Not Available | | LogP | 3.3 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.0 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.129 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.45 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 95.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1338.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 167.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 171.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 162.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 183.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 395.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 365.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 684.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 825.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 326.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 907.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 220.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 290.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 540.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 330.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 105.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Butorphanol,1TMS,isomer #1 | C[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)C2=C1 | 2719.6 | Semi standard non polar | 33892256 | | Butorphanol,1TMS,isomer #2 | C[Si](C)(C)O[C@@]12CCCC[C@@]13CCN(CC1CCC1)[C@@H]2CC1=CC=C(O)C=C13 | 2695.2 | Semi standard non polar | 33892256 | | Butorphanol,2TMS,isomer #1 | C[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O[Si](C)(C)C)C2=C1 | 2684.1 | Semi standard non polar | 33892256 | | Butorphanol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)C2=C1 | 2964.1 | Semi standard non polar | 33892256 | | Butorphanol,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@]12CCCC[C@@]13CCN(CC1CCC1)[C@@H]2CC1=CC=C(O)C=C13 | 2948.9 | Semi standard non polar | 33892256 | | Butorphanol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O[Si](C)(C)C(C)(C)C)C2=C1 | 3166.2 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Butorphanol GC-MS (Non-derivatized) - 70eV, Positive | splash10-05c5-4090000000-ff08db00ae2474f6b4a5 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Butorphanol GC-MS (2 TMS) - 70eV, Positive | splash10-0a4i-6004900000-19e8948f63ea068f317c | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Butorphanol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Butorphanol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Butorphanol GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Butorphanol GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Butorphanol GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Butorphanol GC-MS ("Butorphanol,1TMS,#2" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 10V, Positive-QTOF | splash10-0400-3009000000-2dca83671d56d098a9c9 | 2017-07-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 20V, Positive-QTOF | splash10-02t9-9024000000-f37bfb8ff0e2cf917155 | 2017-07-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 40V, Positive-QTOF | splash10-014i-9000000000-b3868f9e593caf3b586b | 2017-07-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 10V, Negative-QTOF | splash10-004i-0029000000-d2856cd83df5e8d33b65 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 20V, Negative-QTOF | splash10-0a6r-2098000000-a2f7eacf8c80072ad5b6 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 40V, Negative-QTOF | splash10-0a4l-4090000000-37ed14b31b49d2194700 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 10V, Positive-QTOF | splash10-004i-0009000000-8ed73bd9ae49e58d578e | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 20V, Positive-QTOF | splash10-004i-0009000000-3cb1bcbf15b91d40d3a0 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 40V, Positive-QTOF | splash10-017l-5094000000-f351e63d912694f61c8f | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 10V, Negative-QTOF | splash10-004i-0009000000-ad4847b3b72e4c91ee0a | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 20V, Negative-QTOF | splash10-004i-0009000000-ad4847b3b72e4c91ee0a | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Butorphanol 40V, Negative-QTOF | splash10-0ab9-1957000000-6d5cd344c3106be1f9e2 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Fan LW, Tanaka S, Tien LT, Ma T, Rockhold RW, Ho IK: Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain. Brain Res Bull. 2002 Jun;58(2):149-60. [PubMed:12127012 ]
- Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD: The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain. 1999 Nov;83(2):339-45. [PubMed:10534607 ]
|
|---|